BNET Industries

Last Fiscal Year Sales:$3.5B
  • Public
  • US
Dow Jones Description

Retailer of Cardiovascular Therapeutic Devices & Related Products

Director, President & CEOJames R. Tobin
Number of Employees 13,000
Contact Information

111 Monument Cir 29th Fl

PO Box 44906

Indianapolis, Indiana 46204-5100

guidant.com

(317) 971-2000

NAICS Code Diagnostic Imaging Centers: 621512

Recent Events

  • Device Maker Charged With Unlawful Clinical Trials

    6/18/09 - Legal Settlement - View Story

  • Boston Scientific names new chief: Tobin, who oversaw Guidant acquisition, will retire in July

    6/26/09 - Merger / Acquisition - View Story

  • Defective Medical Products - Implantable Cardiac Defibrillators

    5/25/09 - Lawsuit Filed - View Story

  • 8-year study shows defibrillator value

    5/15/09 - Merger / Acquisition - View Story

  • At TCT, New Studies Support Drug-Eluting Stents

    5/04/09 - Merger / Acquisition - View Story

  • Guidant Financial Group Names New CEO

    2/10/09 - Mgmt. Change Entering - CEO - View Story

  • More Earnings Overwhelmed by Impairments

    1/29/09 - Merger / Acquisition - View Story

  • Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2008

    1/29/09 - Merger / Acquisition - View Story

News & Analysis

guidant corp. - All News and Analysis

Decision Makers

Name (plus bio) Position
James R. Tobin Director, President & CEO
Frederick D. Hrkac President of Europe, Middle East & Africa (Emea)
John Pedersen President of The Urology and Gynecology Business
Joseph M Fitzgerald President and General Manager, Peripheral Interventions
Mark Paul President of Neurovascular
Maulik Nanavaty President, Boston Scientific Japan
Michael Phalen President of The Endoscopy Business
Tony Gibbons Regional President, Inter, Continental
Donald S. Baim Executive Vice President, Chief Medical and Scientific Officer
Jeffrey D. Capello Senior Vice President, Chief Accounting Officer and Corporate Controller
Kathleen Lundberg Chief Compliance Officer
Peter Mariani Chief Accounting Officer, Vice President & Controller
Samuel R. Leno Executive Vice President for Finance and Information Systems and Chief Financial Officer
Jim Gilbert Executive Vice President, Strategy and Business Development
Kenneth J. Pucel Executive Vice President, Operations
Lucia Luce Quinn Executive Vice President of Human Resources
Timothy A Pratt Executive Vice President, Secretary and General Counsel
Brian R. Burns Senior Vice President, Quality
David McFaul Senior Vice President, International
Hank Kucheman Senior Vice President
Michael Onuscheck Senior Vice President and President of The Neuromodulation Business
Paul Donovan Senior Vice President
Stephen F. Moreci Senior Vice President & Group President, Endosurgery
William H. Kucheman Senior Vice President and Group President, Cardiovascular
Bernard E. Kury General Counsel & Vice President
Fritz French Vice President, Marketing
Gregory D. Casciaro Vice President of Sales
William A McGinnis Vice President Endocrine Business Unit
William F. McConnell Jr. Vice President for Sales, Marketing and Business Strategy, Crm
Harvey T. Strosberg Senior Partner at Sutts
Blair A. Rieth Director, Investor Relations
Gary Zaro Engineering Director
Randy Ban Director, Therapy Development
Steven Tragash Director, Corp Communications
Annette Ruzicka Manager, Corp Communications, Cardiac Rhythm Management
David Blake Manager
Kimberly Boetsch Manager, Corp Communications, Vascular Intervention
Fred McCoy Head, Cardiac Rhythm Management Division
Roz Harris Senior Financial Analyst
Stacy Mapleton Systems Analyst
Steve Timmerman Testing Liaison
August M. Watanabe Director
Eugene L. Step Director
Nancy-Ann DeParle Director

Board of Directors

Name (plus bio) Position
James Cornelius Chairman Emeritus, Guidant Board of Directors
Enrique C. Falla Board of Directors
Ernest Mario PhD Board of Directors
J. Kevin Moore Board of Directors
J. Raymond Elliott Board of Directors
J.B. King Board of Directors
Jack Shaw Board of Directors
Joel L. Fleishman Board of Directors
John E. Abele Board of Directors
John E. Pepper Board of Directors
Keith E. Brauer Board of Directors
Kristina M. Johnson Board of Directors
Kristina M. Johnston Board of Directors
Mark Novitch Board of Directors
Maurice A. Cox Jr. Board of Directors
Michael Grobstein Board of Directors
Peter M. Nicholas Board of Directors
Ruedi E. Wager Board of Directors
Ursula M. Burns Board of Directors
Uwe E. Reinhardt PhD Board of Directors
W. Gerald Austen Board Member

"Jim Tobin joined Boston Scientific as President and Chief Executive Officer in 1999, bringing with him health care industry leadership and vision that has helped the company build on its dramatic growth. Jim is driving Boston Scientific’s strategic efforts to continue its global leadership position in the field of less-invasive medicine. The company develops, manufactures and markets less-invasive medical devices for use in a broad range of interventional medical specialties. Before joining Boston Scientific, Jim was President and Chief Executive Officer of Biogen, Inc. He managed Biogen’s research and development, manufacturing, marketing and sales. He joined Biogen as President and Chief Operating Officer in 1994 and became President and CEO in 1997. He also served on Biogen’s Board of Directors. Previously, Jim spent 22 years with Baxter International, rising from financial analyst to President and Chief Operating Officer. Between 1972 and 1994, he served as Managing Director in Japan (1975-1977) and Spain (1977-1980), and President of the I.V. Systems Group (1981-1986). He was promoted to Executive Vice President, responsible for running a worldwide business group, in 1988 and became responsible for Baxter’s manufacturing and distribution business in 1990. He served as President and Chief Operating Officer of the 60,000-employee, $9 billion company from 1992 until 1994. Jim serves on the boards of Boston Scientific Corporation, and Curis, Inc., and is involved with the BioMedical Science Career Program. He also served as lieutenant in the U. S. Navy from 1968 to 1972. He holds an A.B. from Harvard College and an M.B.A. from Harvard Business School. "

Organization Position Status
Boston Scientific Corporation President and Chief Executive Officer Current
Guidant Director, President & CEO Current
Celera Genomics Current
Celera Diagnostics, LLC Current
Applied Biosystems Group Co-Chair Current
Boston Scientific Corporation Board of Directors Current
Beth Israel Deaconess Medical Center Board Member Current
Curis, Inc. Board of Directors Current
Applera Corporation Board Member Current
Biogen, Inc. Chief Executive Officer Former
Biogen Idec, Inc. Chief Executive Officer Former
Baxter International Inc. President Former
Curis, Inc. President Former
Biogen Idec, Inc. President Former
Biogen, Inc. President Former
Biogen Idec, Inc. Chief Operating Officer Former
Baxter International Inc. Chief Operating Officer Former
Biogen, Inc. Chief Operating Officer Former
Baxter International Inc. Executive Vice President Former
Baxter International Inc. Managing Director Former
U.S. Navy Lieutenant Former
Baxter International Inc. NA Former
Curis, Inc. Chair Former
Biogen, Inc. Director Former
Applied Biosystems Group Board of Directors Former
Creative BioMolecules, Inc. Board of Directors Former
Harvard Business School M.B.A Former
Harvard College A.B Former

Fred Hrkac is President of Europe, Middle East & Africa (EMEA) at the Boston Scientific Corporation. Before joining Boston Scientific in 2009, Fred was Worldwide President of Sorin Group CRM, where he was responsible for all global business units and sales of more than $350 million. Previously at Sorin, he was Vice President of Global Marketing & Sales responsible for sales of $310 million in a matrix sales organization. Prior to Sorin, Fred spent 14 years with Johnson & Johnson (J&J), where he served in various marketing and senior management positions, including Vice President of International of Biosense Webster (a J&J company). Fred graduated from Wilfrid Laurier University in Ontario, Canada where he earned an Honours Bachelor of Business Administration degree.

Organization Position Status
Guidant President of Europe, Middle East & Africa (Emea) Current
Wilfrid Laurier University Former

"John Pedersen is President of the Urology and Gynecology business at Boston Scientific Corporation. Prior to assuming this role, John was President of the Company’s Peripheral Interventions (PI) business. John lead the PI business through a challenging period of implementing continuous quality improvement programs in the face of increased competition in the market. During this period, he refocused the business strategy to key growth areas within PI with special emphasis on interventional cardiologists and vascular surgeons. Ultimately, John and his team helped combine the PI business unit into a larger cardiovascular group. Prior to his role as President of PI, John served as President of Boston Scientific’s Urology and Gynecology business. Heavy investments were made to sustain leadership in Urology and build a Gynecology business during his first tenure as President. Sales doubled for the business during this period to more than $300 million. Previously, John was President of the Company’s Neurovascular business. He joined the Company in 1996 as Director of New Business Development. Before joining Boston Scientific, John was a Senior Engagement Manager for McKinsey & Company. John earned a B.A. from Princeton University, completed coursework with Thomas Jefferson Medical College, and earned an M.B.A. from Harvard Business School. He is a member of the New England Chapter of the Young President’s Organization. "

Organization Position Status
Boston Scientific Corporation President, Urology and Gynecology Current
Guidant President of The Urology and Gynecology Business Current
Boston Scientific Corporation International President of the Urology and Gynecology Business Current
Young Presidents' Organization Member of New England Chapter Current
Boston Scientific Corporation Director, New Business Development Former
McKinsey & Company, Inc. Senior Engagement Manager Former
Harvard Business School M.B.A Former
Princeton University B.A Former

"Joe Fitzgerald is President and General Manager of the Peripheral Interventions business at Boston Scientific Corporation with overall responsibility for our peripheral vascular and neurovascular business units. Prior to his current role, Joe was President of the Company’s Electrophysiology business. In this role, the business experienced double-digit sales and profitability growth and maintained its market-leading position in the catheter ablation market segment. Previously, Joe held a variety of management positions in Boston Scientific’s Neurovascular and Peripheral Interventions businesses. This included numerous regional and divisional sales management assignments up to and including his roles as Vice President, Global Marketing and U.S. Sales for the Neurovascular business. Joe joined Boston Scientific in 1990 as a sales representative. Prior to joining the Company, Joe was with Anheuser Busch, Inc., where he held a variety of sales, marketing, and training assignments. Joe earned a B.S. in Business from Indiana University and an M.B.A. from Southern Illinois with a concentration in marketing and finance. "

Organization Position Status
Boston Scientific Corporation President, Electrophysiology Current
Guidant President and General Manager, Peripheral Interventions Current
Boston Scientific Corporation Vice President, Sales, Neurovascular Business Former
Boston Scientific Corporation Management Positions, Boston Scientific’S Neurovascular and Peripheral Interventions Businesses Former
Anheuser-Busch Companies, Inc. Sales, Marketing and Training Assignments. Former
Indiana University B.S. Business Former

Mark Paul is President of Neurovascular at Boston Scientific Corporation. Mark joined Boston Scientific in 1991 as territory manager for its Medi-Tech division. Most recently, he served as Vice President and General Manager of Boston Scientific International, leading 10 international business franchises and marketing support functions. Previously, Mark held a variety of marketing positions in the Company's Peripheral Interventions, Neurovascular, Oncology and Vascular Surgery businesses. He was Boston Scientific's first Neurovascular product manager and subsequently held a series of marketing positions with increasing management responsibility, including Director of Marketing in Europe for the Company's Peripheral Interventions, Oncology and Vascular Surgery businesses. Prior to Boston Scientific, Mark held a variety of sales management positions with Procter & Gamble's paper and soap divisions. Mark earned a B.A. in English Literature Studies from the University of Utah where he spent time at the Universite de Neuchatel in Switzerland and Cambridge University in England.

Organization Position Status
Guidant President of Neurovascular Current
Boston Scientific Corporation International Vice President Former
Boston Scientific Corporation International General Manager Former
Cambridge University B.A. In English Literature Studies Former
University of Utah B.A. In English Literature Studies Former

Maulik Nanavaty is President of Boston Scientific Japan at the Boston Scientific Corporation. Maulik joined Boston Scientific in 2005 as Vice President for Corporate Strategy for Japan, where he led a successful business transformation and contributed to a high level of operational efficiency. Most recently, Maulik was Vice President and General Manager of Japan's Interventional Cardiology business. During his tenure, Maulik managed the successful launch of the Company's TAXUS Express2 drug-eluting stent system in Japan. Prior to joining Boston Scientific, Maulik served for 16 years in various executive positions at Baxter International, Inc., and Baxter Japan. Maulik holds a Ph.D. in Pharmaceutical sciences from the University of Illinois and a M.B.A. from the University of Chicago.

Organization Position Status
Guidant President, Boston Scientific Japan Current
University of Chicago PH.D. In Pharmaceutical Former
University of Chicago M.B.A. Former
Organization Position Status
Guidant President of The Endoscopy Business Current
Boston Scientific Corporation International President Current
Boston Scientific Corporation Vice President, Business Unit Former
Boston Scientific Corporation Director, Marketing Former
Boston Scientific Corporation Group Product Manager Former
Fairleigh Dickinson University M.B.A. Former
Villanova University B.S. In General Science Former

Tony Gibbons is Regional President of Inter-Continental at Boston Scientific Corporation, which includes Japan, Asia, Latin America and Canada. Tony joined the Company in 1991 as an Endoscopy sales representative responsible for the Company's Florida territory and most recently was Vice President, International Sales and General Manager. In this role, he was responsible for overall sales execution of the business, which included training and developing more than 1,200 sales representatives and 400 sales managers in 67 countries. He was also responsible for the Company's Canadian operations overseeing more than 125 employees. Previously, he was Vice President and General Manager of the Company's operations in Latin America and Canada, where he increased sales growth by 75 percent. Prior to this, Tony was Country Director of the Company's Canada operations. Prior to Boston Scientific, Tony was with Harris/Lanier Corporation, where he held a variety of sales and sales management roles. Tony earned a B.S. in both Economics and Marketing from Alfred University in 1987.

Organization Position Status
Guidant Regional President, Inter, Continental Current
Alfred University B.S. Former

"Donald S. Baim, M.D., is Executive Vice President, Chief Medical and Scientific Officer at Boston Scientific Corporation as of July 3, 2006. Dr. Baim's primary responsibilities include management of Clinical Affairs (including pre-clinical and clinical studies); Medical Affairs (including educational programs and physician relationships), and Safety. He also plays a major role in developing technology strategies, including the assessment of technologies of acquisition and partnership candidates, and their integration with internal technologies to help develop the Company's future product portfolio. Before joining Boston Scientific, Dr. Baim was a Professor of Medicine at Harvard Medical School, Senior Physician at the Brigham and Women's Hospital, and an internationally recognized leader in interventional cardiology who specialized in the development and evaluation of new interventional cardiovascular devices. He has published nearly 300 scientific papers on interventional cardiology, edited the leading textbook in the field (Grossman's Cardiac Catheterization, Angiography and Intervention, now in its 7th edition), and has served as a member of the Interventional Cardiology Test Committee of the American Board of Internal Medicine (ABIM). Dr. Baim has been the national Principal Investigator on literally dozens of clinical trials in interventional cardiology, and a founder or key consultant for more than 20 start-up companies and medical device incubators in areas ranging from embolic protection, thrombectomy, chronic total occlusions, arterial closure, novel stent and coatings, heart failure, and percutaneous heart valves. He was the recipient of the Career Achievement Award at TCT 2000, based on his clinical, research, and educational contributions to the field. Dr. Baim completed his undergraduate training in Physics at the University of Chicago, and then received a M.D. from Yale University School of Medicine. During post-graduate training in medicine and cardiology at Stanford, he worked with Dr. John Simpson during the development of some of the earliest moveable guidewire coronary angioplasty catheters. In 1981, Dr. Baim was recruited to establish an Interventional Cardiology program at Boston's Beth Israel Hospital. Under his leadership, this program went on to perform seminal research in the refinement, critical evaluation and optimal application of newer devices, including stents, atherectomy, clot removal and distal embolic protection. In 2000, he was recruited by the Brigham and Women's Hospital in Boston, where in addition to his clinical responsibilities, he directed the hospital's participation in the Center for the Integration of Medicine and Innovative Technology (CIMIT), a federally funded inter-disciplinary consortium of leading Boston teaching hospitals and engineering institutions that develops innovative device solutions for a wide range of unmet medical challenges. Since 2005, Dr. Baim has also served as Chief Academic Officer of the Harvard Clinical Research Institute (HCRI), a not-for-profit organization that designs, conducts, and analyzes pilot and pivotal trials of new medical devices to support their approval by the U.S. Food and Drug Administration (FDA). "

Organization Position Status
Boston Scientific Corporation Executive Vice President & Chief Medical and Scientific Officer Current
Boston Scientific Corporation International Executive Vice President, Chief Medical and Scientific Officer Current
Harvard Clinical Research Institute Chief Academic Officer Current
Guidant Executive Vice President, Chief Medical and Scientific Officer Current
Interventional Cardiology Internationally Recognized Leader Former
Harvard Medical School Professor, Medicine Former
Yale University School of Medicine M.D. Former
Yale University School of Medicine M.D Former
University of Chicago Undergraduate Training In Physics Former

Jeff Capello is Senior Vice President, Chief Accounting Officer and Corporate Controller at the Boston Scientific Corporation. Jeff is responsible for overseeing the Company's Global Controllership, Treasury, and Information Systems functions. Prior to joining Boston Scientific in 2008, Jeff was Senior Vice President and Chief Financial Officer for Business Development at PerkinElmer, Inc. Previously, he held a variety of management positions at PerkinElmer, including Vice President of Finance, Corporate Controller and Treasurer and Chief Accounting Officer. Prior to his tenure at PerkinElmer, Jeff held a series of management positions with increasing responsibility at PriceWaterhouseCoopers LLP. Jeff holds a Bachelor of Science degree in business administration from the University of Vermont and a M.B.A. from the Harvard Business School. He is a certified public accountant.

Organization Position Status
Guidant Senior Vice President, Chief Accounting Officer and Corporate Controller Current
Organization Position Status
Guidant Chief Compliance Officer Current
Guidant Senior Vice President, Human Resources Current
Guidant Biostatistician Current
University of Minnesota Master's degree in Biostatistics and Computer Science Former
Organization Position Status
Guidant Chief Accounting Officer, Vice President & Controller Current
Guidant Board of Directors Current
Organization Position Status
Guidant Executive Vice President for Finance and Information Systems and Chief Financial Officer Current
Boston Scientific Corporation Executive Vice President, Finance and Information Systems and Chief Financial Officer Current
Boston Scientific Corporation International Executive Vice President for Finance and Information Systems and Chief Financial Officer Current
TomoTherapy Incorporated Board of Directors Current
Zimmer Holdings, Inc. Board of Directors Current
Arrow Electronics, Inc. Chief Financial Officer Former
Zimmer Holdings, Inc. Chief Financial Officer Former
Zimmer Shanghai CFO & Executive Vice President, Finance & Operations Former
Zimmer Holdings, Inc. Executive Vice President, Finance and Corporate Services Former
Arrow Electronics, Inc. Senior Vice President Former
Baxter International Inc. Former
Roosevelt University MBA Former
Northern Illinois University bachelor's of science degree in accounting Former
Northern Illinois University bachelor's of science degree in accounting Former
Organization Position Status
Boston Scientific Corporation International Executive Vice President, Strategy and Business Development Current
Guidant Executive Vice President, Strategy and Business Development Current
The Cardiovascular Group Group President Former
Organization Position Status
Guidant Executive Vice President, Operations Current
Boston Scientific Corporation Executive Vice President, Operations Current
Boston Scientific Corporation International Executive Vice President, Operations Current
Boston Scientific Corporation General Manager, Operations Former
Boston Scientific Corporation Director, Operations Former
Boston Scientific Corporation Operations Manager Former
Boston Scientific Corporation Process Development Engineer Former
University of Minnesota B.S, Mechanical Engineering Former
University of Minnesota B.S. in Mechanical Engineering with a focus on Biomedical Engineering Former

Lucia Quinn is Executive Vice President of Human Resources at Boston Scientific Corporation. Lucia joined the Company in 2005 and is responsible for company-wide Human Resources efforts, including HR services to all Boston Scientific businesses and functions, as well as corporate recruiting, compensation, benefits, policies, and training. Previously, Lucia was Senior Vice President at Quest Diagnostics Incorporated, a provider of diagnostic testing, information and services. She joined Quest in 2001 as a member of the senior management team and was responsible for a portfolio of businesses with approximately $1 billion in revenue, and for directing investments, acquisitions, product development and key customer contracts. Prior to joining Quest, Lucia was Vice President, Corporate Strategic Marketing for Honeywell International, where she oversaw Honeywell's business portfolio analysis and strategic marketing groups. Previously, Lucia held a variety of leadership positions in global technology companies Westinghouse, Digital Equipment, Compaq and AlliedSignal. Lucia graduated from Simmons College where she earned a B.A. in Management. She currently chairs the Board of Trustees at Simmons College and is an overseer of the Museum of Science in Boston. Lucia is also a member of The Committee of 200, an organization of leading businesswomen.

Organization Position Status
Guidant Executive Vice President of Human Resources Current
Boston Scientific Corporation International Executive Vice President of Human Resources Current
Boston Scientific Corporation Executive Vice President, Human Resources Current
QMed, Inc. Board of Directors Current
Quest Diagnostics Incorporated Senior Vice President Former
Honeywell International Inc. Vice President, Corporate Strategic Marketing Former
Quest Company Former
Simmons College Chair, Board of Trustees Former
Simmons College B.A., Management Former
Quest Diagnostics Incorporated Member, Senior Management Team Former
Organization Position Status
Boston Scientific Corporation International Executive Vice President, Secretary and General Counsel Current
Guidant Executive Vice President, Secretary and General Counsel Current
Boston Scientific Corporation International General Counsel Current
Boston Scientific Corporation International Secretary Current
S-Hook Co-Chair Former
Tarkio College Bachelor of Arts Degree Former
Drake University Law School Former
Organization Position Status
Boston Scientific Corporation International Senior Vice President, Quality Current
Guidant Senior Vice President, Quality Current
Boston Scientific Corporation Vice President, Quality Current
Allegiance Healthcare Corporation General Manager Former
Boston Scientific Corporation Director, Quality Former
University of Arkansas B.S. Chemical Engineering Former

David McFaul is Senior Vice President of International at Boston Scientific Corporation. Prior to this role, David was Regional President of Asia-Pacific & Japan operations. He joined the Company in 1995 to oversee the development of the Company's Canadian business and most recently was President of the Company's Japan operations. Prior to this, David was Vice President of Sales, Inter-Continental. In this role, he was responsible for overall sales execution for the businesses, which included training and developing more than 400 sales representatives and 85 sales managers in 35 countries. He also implemented a new "on-boarding" program for new hires, developed a clinical training program, and created a high-performance sales management program for the Inter-Continental business. Previously, he was Vice President and General Manager of the Company's operations in Latin America, Canada and South Africa where he increased revenue nearly 50 percent. Prior to this, David was General Manager, Canada and South Africa, Country Manager of Canada and National Sales Manager, Canada for the Company. Prior to Boston Scientific, David held sales, marketing and general management positions at a variety of medical-related companies including Stryker Corporation, EBI Medical Systems, Baxter Corporation, and Abbott Labs. David earned a B.A. in History and Geography from Simon Fraser University and took graduate courses at Simon Fraser University Graduate School.

Organization Position Status
Guidant Senior Vice President, International Current
Boston Scientific Corporation International Senior Vice President Current
Simon Fraser University B.A. In History and Geography Former
Organization Position Status
Boston Scientific Corporation International Group President Current
Guidant Senior Vice President Current
Boston Scientific Corporation International Senior Vice President Current
Virginia Polytechnic Institute and State University M.B.A. Former
Virginia Polytechnic Institute and State University B.S. Former
Organization Position Status
Boston Scientific Corporation International President Current
Guidant Senior Vice President and President of The Neuromodulation Business Current
Pfizer Inc. Former
Washington & Jefferson College B.A. In Business Administration Psychology Former

Paul Donovan is Senior Vice President for Corporate Communications at Boston Scientific Corporation. He is responsible for the Company's communications activities, including media relations, employee communications and brand identity. He also serves as the Company's spokesman. Paul brings more than 25 years of communications experience to Boston Scientific. Before joining the Company in 2000, he was Executive Director of External Affairs at Georgetown University Medical Center. Previously he was Chief of Staff at the U.S. Department of Commerce. He served for 10 years on the staff of Senator Edward M. Kennedy, first as Press Secretary and later as Chief of Staff. Prior to that he served as a press aide to Senator John F. Kerry. He holds a B.A. from Dartmouth College. He serves on the Board of Directors of the Massachusetts Medical Device Industry Council and the Massachusetts High Tech Council, and he is an Overseer of Children's Hospital in Boston.

Organization Position Status
Guidant Senior Vice President Current
Boston Scientific Corporation International Senior Vice President for Corporate Communications Current
Georgetown University Medical Center Executive Director of External Affairs Former
The Press Secretary Former
Dartmouth College B.A. Former

Steve Moreci is Senior Vice President and Group President for Endosurgery responsible for Boston Scientific's Endoscopy, Urology/Gynecology and Oncology businesses. Steve joined Boston Scientific in 1989 as Vice President and General Manager for the Cardiac Assist business. In 1991, he was appointed Vice President and General Manager for the newly formed Endoscopy business. In 1994, Steve was given the additional responsibility for the company's Urology and Gynecology business and was promoted to Group Vice President.

Organization Position Status
Guidant Senior Vice President & Group President, Endosurgery Current
Organization Position Status
Guidant Senior Vice President and Group President, Cardiovascular Current
Organization Position Status
Guidant General Counsel & Vice President Current
Eli Lilly and Company Former
Princeton University A.B. degree Former
Organization Position Status
Guidant Vice President, Marketing Current

Array

Organization Position Status
Xtent Inc. President, Chief Executive Officer and Director Current
Guidant Vice President of Sales Current
Kerberos Proximal Solutions, Inc. member Current
United States Surgical Corporation Current
Angiodynamics, Inc. Board of Directors Current
Xtent Inc. Director Current
Namic, Inc. Chief Executive Officer Former
Namic, Inc. President Former
Gourmet Services Inc. Vice President of Sales and Marketing Former
Marquette University B.A. In Business Administration Former

Mr. McGinnis joined Acera in July 2004 after serving as President & CEO of two biotechnology companies in Canada. Prior to those responsibilities, he was employed in a variety of management roles at Eli Lilly and Company throughout the United States and Canada. His responsibilities included General Manager of Hybritech Imaging and Therapeutics in San Diego, General Manager of Medical Devices and Diagnostics (now Guidant Canada), Vice President of Endocrine Business Unit (Canada) and Segment Leader of Institutional Accounts for Lilly USA. His career at Eli Lilly spanned 27 years.

Organization Position Status
Acera Biosciences, Inc President & CEO Current
Guidant Vice President Endocrine Business Unit Current
Guidant General Manager Former
Eli Lilly and Company Former
Organization Position Status
Vesalius Ventures Chief Information Officer Current
Guidant Vice President for Sales, Marketing and Business Strategy, Crm Current
Trustee Leadership Development Chairman Current
Vesalius Ventures Board Member Current
Global Healthcare Exchange, LLC board member Current
Guidant Chief Information Officer Former
Guidant Senior Vice President, Administration Former
Arthur Andersen LLP Managing Partner Former
Accenture Ltd. Managing Partner Former
Miami University Bachelor of Science degree Former

Harvey T. Strosberg, Q.C., LL.D, D.C.L. is a senior partner at Sutts, Strosberg LLP. He was called to the Ontario bar in 1971 and is also a member of the Alberta bar. He has been a bencher (director) of the Law Society of Upper Canada (Law Society of Ontario) since 1987 and served as its Treasurer (President) from 1997 to 1999. His practice is concentrated in civil litigation with his main focus on commercial and class action litigation. Mr. Strosberg has extensive trial and appellate experience in the areas of negligence, personal injury, product liability, insurance law, commercial disputes and class actions. He is the editor of The Canadian Class Action Review and is an adjunct professor of law at the University of Windsor and teaches a course in class action law.

Organization Position Status
Guidant Senior Partner at Sutts Current
Manulife Senior Partner at Sutts Current
Nelbar Financial Corporation Senior Partner at Sutts Current
VIA Rail Canada Inc. Senior Partner at Sutts Current
Moneymart.com Senior Partner at Sutts Current
Stop 'n' Cash Senior Partner at Sutts Current
University of Windsor Adjunct Professor Current
Organization Position Status
Guidant Director, Investor Relations Current

Gary Zaro is a Quality Manager/Engineering Director with 30 years experience in quality and reliability engineering in production and new product development in diverse environments, including 16 years of Medical Device experience at Guidant Corp. He has an MS-Physics from San Jose State University, and is an ASQ Certified Quality Manager and Certified Quality Engineer. As Quality Manager for Guidant Endovascular Solutions, Gary managed numerous quality programs, including evaluation of peripheral, carotid, neurological stent and embolic protection systems requiring CE Mark and Food & Drug Administration 510K approval and Investigation Exemption (IDE) submissions. He managed review and approval of new product development process validation and approved project risk analyses. As Principal Quality Engineer for Guidant Endovascular, Gary completed a peripheral stent system project from concept phase to market release; he wrote the project risk analysis, quality plan, test methods, and filed test reports and protocols. Earlier, as Engineering Director for Guidant Vascular Intervention, Gary managed evaluation of coronary stent systems requiring FDA Pre-Market Approval and Investigational Exemption (IDE) submissions. As Reliability Department head for Guidant Vascular Intervention, Gary managed evaluation of balloon dilatation catheters, guide wires, and accessories requiring FDA Pre-Market Approval (PMA), Investigational Device Exemption (IDE) and 510k submissions. Gary's earliest experience was in regulatory compliance, quality engineering and reliability engineering with Victor Technologies, Xerox, Acurex and Westinghouse Corp. Most recently, Gary has been consulting in quality program management. Recent assignments included completing quality system corrective actions to close out audit action items and processing and investigating complaints for CryoVascular Systems.

Organization Position Status
Guidant Engineering Director Current
Guidant Quality Manager Current
Aqsn Current
Organization Position Status
Guidant Director, Therapy Development Current
Organization Position Status
Guidant Director, Corp Communications Current
Organization Position Status
Guidant Manager, Corp Communications, Cardiac Rhythm Management Current

After retiring from the US Air Force, David and his family settled in the Temecula Valley. He and his wife, Terry, have four children. He serves as the Associate Vice President for Human Resources for the National University System. His prior experience includes a twenty year career with the United States Air Force. He holds a BA in Vocational Education from Southern Illinois University, a MA in Management from University of Redlands and is currently completing a PhD in Organizational Development from Capella University. Dave is the immediate past president of the Habitat for Humanity Board of Directors serving in that capacity for four years. Not a newcomer to Habitat, David previously helped build houses in Alabama and Florida.

Organization Position Status
National University System Associate Vice President for Human Resources Current
Guidant Manager Current
University of Redlands Adjunct Faculty Member Current
Habitat for Humanity Inland Valley President Former
Southern Illinois University BA In Vocational Education Former
Organization Position Status
Guidant Manager, Corp Communications, Vascular Intervention Current
Organization Position Status
Guidant Head, Cardiac Rhythm Management Division Current

Array

Organization Position Status
Hrc Consultants Inc Current
Florida A&M University Former
Goldman, Sachs & Co. Equity Research Analyst Former
Organization Position Status
Filter Market, LLC Coo Current
Guidant Systems Analyst Current
Organization Position Status
Swat Solutions, Inc. President Current
Swat Lab, Inc. Steve Timmerman Cto Current
Guidant Testing Liaison Current
Mhta Co Current
UnitedHealth Group Incorporated Former
Swat Lab, Inc. Founder Current
Mankato State University BS Degree In Computer Science Former

Prior to joining Bristol-Myers Squibb, Jim served as chairman emeritus of the Guidant Board of Directors upon closing of its merger into Boston Scientific in April 2006. He had previously served as chairman and CEO during the merger process and was responsible for the company's initial public offering and subsequent split-off from Eli Lilly and Company. Jim was a member of the Board of Directors of Lilly, a member of its Executive Committee and chief financial officer from 1983 to 1995. From 1980-1982, he served as president and CEO of IVAC Corporation, previously a Lilly subsidiary. He continues to serve on the Boards of Given Imaging Ltd. and DIRECTV Group. Jim has received several honorary doctorate degrees in recognition of his civic and philanthropic activities in Indiana. Jim is president of the Cornelius Family Foundation and has served United Way of Central Indiana in several leadership positions. Jim's passion is football. "I'm a Colts fan because they have been so successful on the field. They have one star who gets all the press, but it's a team effort. I like successful teams in sports and in business and our plan for Bristol-Myers Squibb is to be successful, both for our patients and for our stockholders." Jim was born in Kalamazoo, Michigan, and attended Michigan State University, where he earned a bachelor's degree magna cum laude in accounting in 1965 and an MBA in 1967. He is married with two adult children.

Organization Position Status
Bristol-Myers Squibb Company Chairman and CEO, View Biography Current
Twilight Venture Partners, LLC Senior Managing Partner Current
The DIRECTV Group, Inc. Class II Director Current
Given Imaging Ltd. Outside Director Current
Leerink Swann & Company Current
Guidant Chairman Emeritus, Guidant Board of Directors Current
The DIRECTV Group, Inc. Chairman, Audit Committee Current
The Chubb Corporation Chairman of the Audit Committee Current
National Bank of Indianapolis Corp. Board of Directors Current
Given Imaging Ltd. Director Current
American United Mutual Insurance Holding Company, Inc. Director Current
Digital Keystone Board of Directors Current
Hughes Electronics Director Current
Given Imaging Ltd. Member of the Audit Committee Current
IVAC Corporation CEO Former
IVAC Corporation President Former
Guidant Chief Financial Officer Former
Eli Lilly and Company CFO Former
Eli Lilly and Company vice president Former
Twilight Venture Partners, LLC Co-Founder Former
Guidant Co-Founder Former
Guidant Senior Executive Former
Compuserve Interactive Services, Inc. Former
Boston Scientific Corporation Board Chairman Former
Johnson & Johnson Board Chairman Former
The Chubb Corporation Board Director Former
Guidant Board of Directors Former
The DIRECTV Group, Inc. Director Former
Johnson & Johnson Board of Directors Former
Eli Lilly and Company Board Member Former
Michigan State University MBA Former
Michigan State University BA, Accounting Former
The DIRECTV Group, Inc. Member of the Compensation Committee Former
Digital Keystone Member Former
The DIRECTV Group, Inc. Member Former

Dr. Watanabe serves as Volunteer Chairman of BioCrossroads, Indiana 's leading public-private life science network. He retired from Eli Lilly and Company in June of 2003, as Executive Vice President, Science and Technology, and President of Lilly Research Lab. He remains on the company's Board of Directors. He has also been involved with Guidant Corporation since 2001 as Board Member and Chair of the Board Science and Technology Strategy Committee. Dr. Watanabe is the Former Chairman, Department of Medicine (1983-1990) of Indiana University School of Medicine, where he was involved with cardiac research, teaching, and practice from 1975 to 1990. Previously, he completed post-graduate work in cardiology and clinical pharmacology. He is a Director of Endocyte and QuatRx Pharmaceutical Company. Dr. Watanabe earned his MD at Indiana University School of Medicine.

Organization Position Status
Twilight Venture Partners, LLC Partner Current
Frazier Healthcare Ventures Senior Advisor Current
Damon Runyon Cancer Research Foundation Director Current
Kalypsys, Inc. Board Member, Vice Chairman Current
Reliant Pharmaceuticals, Inc. Member of the Board Current
Twilight Venture Partners, LLC Board of Directors Current
Guidant Director Current
Indiana University Foundation Director Current
Endocyte, Inc. Director Current
Ambrx, Inc. Director Current
Quatrx Pharmaceuticals Co Director Current
Kalypsys, Inc. Director Current
International School of Indiana Board of Directors Current
Indiana University Foundation Vice Chairman Current
Lilly Research Laboratories President Former
Eli Lilly and Company President Former
Eli Lilly and Company Executive Vice President Former
Lilly Research Laboratories Vice President Former
Eli Lilly and Company Director and Executive Former
Guidant Board Science and Technology Strategy Committee Former
American College of Cardiology Officer Former
American Heart Association, Inc. Officer Former
Indiana University School of Medicine Full Time Faculty Member Former
Eli Lilly and Company Executive Officer Former
The National Institute of Mental Health Former
Regenstrief Institute, Inc Chairman Former
Regenstrief Institute, Inc Director Former
Depart-Ment Board of Directors Former
American Heart Association, Inc. Member of the Board of Directors Former
American College of Cardiology board of trustees Former
Lilly Research Laboratories Director Former
Department of Medicine Board of Directors Former
Eli Lilly and Company Director Former
Indiana University School of Medicine Board of Directors Former
Indiana University School of Medicine MD Former
Indiana University doctor of medicine degree Former
Wheaton College Bachelor of Science Degree In Zoology Former
Indiana University School of Medicine Degree Former
National Institutes of Health Member Former
Organization Position Status
Guidant Board of Directors Current
The Dow Chemical Company senior consultant Former
Organization Position Status
Prestwick Pharmaceuticals, Inc Chairman, Pharmaceutical Product Development, Chairman and CEO, Capnia Current
CAPNIA, Inc. Chairman & CEO Current
Park Avenue Equity Partners Partner Current
ICOS Corporation Lead Director Current
University of Rhode Island Adjunct Professor Current
Duke University Trustee Current
University of Maryland Advisor Current
Galileo Pharmaceuticals, Inc. Chairman of the Board of Directors Current
Duke University Health System Board of Directors Current
Multiple Myeloma Board of Directors Current
Pathway Diagnostics Corporation Board of Directors Current
Rare Diseases Clinical Research Network Board of Directors Current
Pharmaceutical Product Development, Inc. Director Current
Maxygen, Inc. Board of Directors Current
Celgene Corporation Board of Directors Current
Boston Scientific Corporation Board of Directors Current
Guidant Board of Directors Current
Pharmion Corporation Board of Directors Current
Lead Discovery Board of Directors Current
Caliper Life Sciences, Inc. Vice-Chairman Current
The Reader's Digest Association, Inc. Director Current
Ardea Biosciences, Inc.De Chief Executive Officer Former
Alza Technologies Corp CEO Former
Reliant Pharmaceuticals, Inc. Chief Executive Officer Former
Reliant Pharmaceuticals, Inc. Chief Executive Former
Bay City Capital LLC Vice President Former
Lee Enterprises, Inc. Publisher Former
ALZA Corporation Executive Officer Former
Squibb Corporation Former
ALZA Corporation Chairman Former
Alza Technologies Corp Chairman Former
The American Foundation Chairman Former
Reliant Pharmaceuticals, Inc. Chairman of the Board Former
Ardea Biosciences, Inc.De Chairman Former
Duke University Health System Chairman of The Board Former
Alexza Pharmaceuticals, Inc. Board of Directors Former
University of Rhode Island Master's and Doctoral Degrees In Physical Sciences Former
Rutgers University B.S. In Pharmacy Former
Princeton University Ab Degree Former

Mr. Step was appointed a director of Cell Genesys in March 1993. From 1973 to 1992, Mr. Step served in various positions in senior management of Eli Lilly and Company, most recently as executive vice president, president of the pharmaceutical division and a member of the board of directors and its executive committee. He was chairman of the board of the Pharmaceutical Manufacturers Association and a past president of the International Federation of Pharmaceutical Manufacturers Association. He is also a director of Scios, Inc., Medco, Inc., Guidant Corporation, Pathogenesis Corporation and DBT Online Inc. Mr. Step holds a B.A. degree in economics from the University of Nebraska and an M.S. in finance and accounting from the University of Illinois.

Organization Position Status
Cell Genesys, Inc. Board of Directors Current
Ceregene, Inc. Professional Board Director Current
Guidant Director Current
Eli Lilly and Company Executive Vice President - Former
Eli Lilly and Company member Former
University of Illinois M.S. In Finance and Accounting Former
University of Nebraska B.A. Degree In Economics Former
Organization Position Status
Guidant Board of Directors Current
Arbor Group managing partner Former
Organization Position Status
Guidant Board of Directors Current
Organization Position Status
Guidant Board of Directors Current
Organization Position Status
Globecomm Systems Inc. President and Chief Executive Officer Current
Globecomm Systems Inc. Board of Directors Current
Guidant Board of Directors Current
SIRIUS XM Radio Inc. Board of Directors Current
Hughes Network Systems, LLC Chief Executive Officer Former
Institute of Electrical and Electronics Engineers, Inc. senior member Former
Hughes Network Systems, LLC Chairman Former
XM Satellite Radio Holdings, Inc. Board of Directors Former
Purdue University B.S. In Electrical Engineering Former

Joel L. Fleishman has been a Director of Boston Scientific since 1992. He is also Professor of Law and Public Policy at Duke University where he has served in various administrative positions, including First Senior Vice President, since 1971. Mr. Fleishman is a founding member of the governing board of the Duke Center for Health Policy Research and Education and was the founding director from 1971 to 1983 of Duke University's Terry Sanford Institute of Public Policy. He is the director of the Samuel and Ronnie Heyman Center for Ethics, Public Policy and the Professions and the director of the Duke University Philanthropic Research Program. From 1993 to 2001, Mr. Fleishman took a part time leave from Duke University to serve as President of the Atlantic Philanthropic Service Company, the U.S. program staff of Atlantic Philanthropies. Mr. Fleishman also serves as a member of the Board of Trustees of The Center for Effective Philanthropy and the Partnership for Public Service, Chairman of the Board of Trustees of the Urban Institute, Chairman of The Visiting Committee of the Kennedy School of Government, Harvard University, and as a director of Polo Ralph Lauren Corporation. Mr. Fleishman received A.B., M.A. and J.D. degrees from the University of North Carolina at Chapel Hill, and an LL.M. degree from Yale University.

Organization Position Status
Boston Scientific Corporation Senior Vice President Current
Duke University Professor , Law and Public Policy Studies Current
The Foundation Co-Author Current
Duke Law School Professor Current
The Samuel and Ronnie Heyman Center Professor of Law Current
James River Group, Inc. Board of Directors Current
Case At Duke Professor of Law and Public Policy, Duke University, Founding Co-Chair Current
Harvard University Chairman, Visiting Committee, Kennedy School of Government Current
James River Group, Inc. Chairman Current
Jewish Theological Seminary Board of Directors Current
Brandeis University Board of Directors Current
The Samuel and Ronnie Heyman Center Director Current
Partnership for Public Service Board of Directors Current
Boston Scientific Corporation Board of Directors Current
Polo Ralph Lauren Corporation Board of Directors Current
Guidant Board of Directors Current
Duke University Director Current
Stonewood Insurance Company Director Current
The Center for Effective Philanthropy Director Current
Brandeis University Trustee Current
Jewish Theological Seminary Trustee Current
The Atlantic Philanthropies President Former
The Foundation Editor Former
Urban Institute Chairman, Board of Trustees Former
Arts and Sciences Chairman Former
American Hebrew Academy Board of Directors Former
The University of North Carolina at Chapel Hill J.D. Degrees Former
The University of North Carolina at Chapel Hill M.A. Former
Yale University Ll.M Former
The University of North Carolina at Chapel Hill A.B. Former
Yale University A.B. Former
The University of North Carolina Former
American Hebrew Academy Trustee Former
Organization Position Status
Fifty Lessons Ltd. Founder Current
The Kingbridge Centre Owner Current
F.I.R.S.T Chairman Current
Cimit Board of Directors Current
Fifty Lessons Ltd. Board of Directors Current
Guidant Board of Directors Current
Philips Solid-State Lighting Solutions Board of Directors Current
Boston Scientific Corporation Board of Directors Current
Usfirst.Org Board of Directors Current
Medical Information Technology Inc. President Former
Boston Scientific Corporation Founder Former
Advanced Instruments, Inc. Sales, Technical and General Management Positions Former
Boston Scientific Corporation Vice Chairman Former
Amherst College Former
Organization Position Status
Guidant Board of Directors Current

Mr. Brauer was CFO of Guidant from the company's inception until it was acquired by Boston Scientific in 2006. While at Guidant, he was also responsible for information systems, treasury and investor relations. Prior to joining Guidant, Mr. Brauer spent 20 years with Eli Lilly and Company, where he held various positions, including Executive Director, International Finance and Chief Accounting Officer; Director of Corporate Affairs; Vice President of Finance and Treasurer for its Physio-Control subsidiary; Controller of its Elizabeth Arden subsidiary; and Coordinator of Business Planning for its Medical Devices and Diagnostics division. Mr. Brauer was also a financial analyst for Ford Motor Company and a member of the Air National Guard. Mr. Brauer currently serves as a member of the Board of Directors and finance committee for Community Hospitals of Indiana and is the Audit Committee Chair and a Member of the Board of Directors of Suros Surgical Systems, Inc., and Endocyte, Inc. He holds a B.S. from Indiana University and an M.B.A. from the University of Michigan.

Organization Position Status
NanoInk, Inc. Board of Directors Current
Guidant Board of Directors Current
Suros Surgical Systems, Inc. Board of Directors Current
Endocyte, Inc. Board of Directors Current
Beta Gamma Sigma Board of Directors Current
Indiana, Inc. Board of Directors Current
Indiana, Inc. Member Current
Eli Lilly and Company chief accounting officer Former
Guidant Chief Financial Officer Former
Guidant Vice President of Finance Former
Eli Lilly and Company executive director Former
Mdd administrator Former
International Finance Corporation Former
University of Michigan M.B.A. Former
Indiana University B.S. Former
Organization Position Status
Southeast Techinventures, Inc Co-Founder and Board Member Current
Duke University Dean of the Edmund T. Pratt, Jr. School of Engineering Current
Pratt School of Engineering at Duke University Dean Current
Spie Director Current
Guidant Board of Directors Current
Nortel Board of Directors Current
Dycom Industries, Inc. Director Current
Boston Scientific Corporation Board of Directors Current
The AES Corporation Director Current
Minerals Technologies, Inc. Board of Directors Current
Duke University Chief Former
Colorlink, Inc. Cofounder Former
University of Colorado co-founder Former
University of Colorado Professor of Electrical and Computer Engineering Former
University of Edinburgh Faculty Department of Electrical Engineering Former
Southeast Techinventures, Inc Dean of Duke University's Pratt School of Engineer Former
The Johns Hopkins University Dean Former
Jhpiego Chair Former
Phi Beta Kappa Board of Directors Former
Stanford University Ph.D. In Electrical Engineering Former
Stanford University M.S. Former
Stanford University B.S. Former
University of Colorado Professor of Electrical and Computer Engineering Former
Phi Beta Kappa Member Former
Organization Position Status
Guidant Board of Directors Current
Organization Position Status
Guidant Board of Directors Current
Fda.Com commissioner Former
Neurogen Corporation Board of Directors Former
Organization Position Status
Guidant Board of Directors Current
Organization Position Status
Guidant Board of Directors Current
Given Imaging Ltd. Director Current
Bristol-Myers Squibb Company Director Current
Ernst & Young vice chairman Former
University of Illinois B.Sc. In Accounting Former
Organization Position Status
Ccmp Capital Advisors, LLC Managing Director Current
Wharton Graduate School of the University of Pennsylvania National Consultant Current
Robert Wood Johnson Foundation Trustee Current
Lingologix Board of Directors Current
MRI & Imaging of Midtown Board of Directors Current
West Paces Diagnostic Imaging LLC Board of Directors Current
Open MRI of Simpsonville Board of Directors Current
Vienna Diagnostic Imaging, Inc Board of Directors Current
Drug Safety Board of Directors Current
Carolinas Diagnostic Imaging Board of Directors Current
Bridgeton MRI Board of Directors Current
Bridge Medical, Inc. Board of Directors Current
Robert Wood Johnson Foundation Board of Directors Current
Accredo Health, Incorporated Director Current
Cerner Corporation Director Current
Triad Hospitals, Inc. Director Current
Boston Scientific Corporation Board of Directors Current
DaVita, Inc. Director Current
Guidant Director Current
Hcfa.Com Administrator Former
Harvard University Fellow, Institute of Politics and the Interfaculty Health Policy Forum Former
The Wharton School of the University of Pennsylvania Adjunct Professor Former
Human Services Inc Commissioner Former
Health Care Financing Administration Administrator Former
Harvard Law School Juris Doctorate Former
Balliol College M.A. In Politics and Economics Former
University of Oxford Master's Degree In Politics and Economics Former
University of Oxford Bachelors Degree Former
The University of Tennessee Bachelor's Degree Former
Organization Position Status
Guidant Board of Directors Current
Organization Position Status
Guidant Board of Directors Current
Organization Position Status
Guidant Board of Directors Current
Organization Position Status
Duke University Health System Trustee Current
Princeton University Professor , Political Economy Current
Duke University Trustee Current
University of Cambridge Senior Associate Current
National Academy of Sciences Current
Amerigroup Corporation Nominating and Corporate Governance Committee Chairman Current
Duke University Health System Member, Board of Trustees Current
Duke University Member, Board of Trustees Current
Boston Scientific Corporation Board of Directors Current
Triad Hospitals, Inc. Director Current
Guidant Board of Directors Current
Hxti Board of Directors Current
Ferrer, Freeman & Company, Inc. Board of Directors Current
Amerigroup Corporation Member Current
Triad Hospitals, Inc. Audit Committee Member Current
Duke University Health System Trustee Current
Amerigroup Corporation Board Director Former
Yale University Ph.D. Former
Princeton University Ph.D Former
Yale University Master's Degree Former
University of Saskatchewan Bachelor In Commerce Degree Former

Dr. W. Gerald Austen, M.D., has served as a Director of the Company since 1985. Since 1974 he has been the Edward D. Churchill Professor of Surgery at Harvard Medical School and at Massachusetts General Hospital. From 1969 to 1997, Dr. Austen was Chief of the Surgical Services at Massachusetts General Hospital. Dr. Austen is the former President of the American College of Surgeons, the American Association for Thoracic Surgery, the American Surgical Association and the Massachusetts and American Heart Associations. Dr. Austen is a member of the Institute of Medicine of the National Academy of Sciences, a Fellow of the American Academy of Arts and Sciences, a life member of the corporation of the Massachusetts Institute of Technology and Chairman of the Board of Trustees of the John S. and James L. Knight Foundation. Mr. Ronald W. Dollens joined ABIOMED's Board of Directors in January 2006. Mr. Dollens is the retired President and Chief Executive Officer and founding board member of Guidant Corporation, the $3.7 billion company he formed following its split-off from Eli Lilly and Company in 1995. Prior to his position at Guidant, Mr. Dollens was President of Eli Lilly's Medical Devices and Diagnostics Division (MDD). Mr. Dollens' industry leadership includes the position as past Director and Chairman of the Board of the Advanced Medical Technology Association (AdvaMed), the world's largest medical technology association; as well as past Chairman of the Healthcare Leadership Counsel. He has served on the Advisory Committee on Regulatory Reform, a group appointed by former U.S. Health and Human Services Secretary Tommy G. Thompson.

Organization Position Status
ABIOMED, Inc. Life Member Current
Bioinnovation Institute Current
The Johns Chairman Current
Guidant Board Member Current
ABIOMED, Inc. Board of Directors Current
Massachusetts General Hospital Board of Directors Current
National Academy of Sciences Member Current
American College of Surgeons President Former
Eli Lilly and Company President Former
Guidant President Diagnostics Division Former
Massachusetts General Hospital Chief of the Surgical Services Former
Massachusetts General Hospital Professor Former
University of Athens Degrees Former
The University of Akron Degrees Former
Harvard Medical School Former

Executive News

  • Natick: New CEO Elliott was BSX director

    MetroWest Daily News - 6/26/09 - View Story

  • Change at Top Looks Good for Bottom Line

    Motley Fool via MSN Money - 6/26/09 - View Story

  • Boston Scientific names new president and CEO

    TradingMarkets - 6/26/09 - View Story

  • Ex-Zimmer boss in new job

    Journal-Gazette - 6/26/09 - View Story

  • Boston Scientific names new chief: Tobin, who oversaw Guidant acquisition, will retire in July

    TradingMarkets - 6/26/09 - View Story

  • Sallie Mae Rises 10%; Nike Declines 3.3%

    The Wall Street Journal Interactive Edition - 6/26/09 - View Story

  • Boston Scientific names Elliott CEO as Tobin steps down

    Boston Globe - 6/26/09 - View Story

  • Boston Scientific CEO to Leave Post

    The Wall Street Journal Interactive Edition - 6/26/09 - View Story

  • Ex-Zimmer exec to lead Boston Scientific

    Journal-Gazette - 6/25/09 - View Story

  • 2nd UPDATE: Boston Sci CEO To Retire; Ray Elliott Fills Post

    Morningstar.com - 6/25/09 - View Story

  • CORRECTED-UPDATE 4-Boston Sci CEO retires; former Zimmer chief in

    Forbes.com - 6/25/09 - View Story

  • Former Zimmer CEO to run Boston Scientific

    Greater Fort Wayne Business Weekly - 6/25/09 - View Story

  • CORRECTED - UPDATE 4-Boston Sci CEO retires; former Zimmer chief in

    Reuters - 6/25/09 - View Story

  • New Boston Sci CEO Brings Strong Legacy, But Also Questions

    CNN Money - 6/25/09 - View Story

  • Boston Scientific CEO James Tobin to Retire in July

    Smart Money - 6/25/09 - View Story

  • UPDATE: Boston Sci's CEO To Retire; Ray Elliott To Fill Post

    CNN Money - 6/25/09 - View Story

  • Boston Scientific Names Ray Elliott CEO, President

    ABC News - 6/25/09 - View Story

  • Boston Scientific CEO Tobin resigns

    Boston Business Journal - 6/25/09 - View Story

  • BRIEF: Boston Scientific taps new CEO

    TradingMarkets - 6/25/09 - View Story

  • Boston Scientific (BSX) NewsBite - BSX CEO Announces Retirement

    Market Intelligence Center - 6/25/09 - View Story

advertisement
advertisement